Open access · CC-BY
via OpenAlex
Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes
Domenico Mattiucci, Giulia Maurizi, Pietro Leoni, Antonella Poloni
Cell Transplantation · 2018 · ▲ 54 citations
Abstract
Hematopoietic stem and progenitor cells reside within the bone marrow (BM) microenvironment. By a well-balanced interplay between self-renewal and differentiation, they ensure a lifelong supply of mature blood cells. Physiologically, multiple different cell types contribute to the regulation of stem and progenitor cells in the BM microenvironment by cell-extrinsic and cell-intrinsic mechanisms. During the last decades, mesenchymal stromal cells (MSCs) have been identified as one of the main cellular components of the BM microenvironment holding an indispensable role for normal hematopoiesis. During aging, MSCs diminish their functional and regenerative capacities and in some cases encounter replicative senescence(definition), promoting inflammation and cancer progression. It is now evident that alterations in specific stromal cells that comprise the BM microenvironment can contribute to hematologic malignancies, and there is growing interest regarding the contribution of MSCs to the pathogenesis of myelodysplastic syndromes (MDSs), a clonal hematological disorder, occurring mostly in the elderly, characterized by ineffective hematopoiesis and increased tendency to acute myeloid leukemia evolution. The pathogenesis of MDS has been associated with specific genetic and epigenetic events occurring both in hematopoietic stem cells (HSCs) and in the whole BM microenvironment with an aberrant cross talk between hematopoietic elements and stromal compartment. This review highlights the role of MSCs in MDS showing functional and molecular alterations such as altered cell-cycle regulation with impaired proliferative potential, dysregulated cytokine secretion, and an abnormal gene expression profile. Here, the current knowledge of impaired functional properties of both aged MSCs and MSCs in MDS have been described with a special focus on inflammation and senescence induced changes in the BM microenvironment. Furthermore, a better understanding of aberrant BM microenvironment could improve future potential therapies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1177/0963689717745890
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Mattiucci, D., Maurizi, G., Leoni, P., & Poloni, A. (2018). Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes. <em>Cell Transplantation</em>. https://doi.org/10.1177/0963689717745890
Vancouver
Mattiucci D, Maurizi G, Leoni P, Poloni A. Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes. Cell Transplantation. 2018. doi:10.1177/0963689717745890.
BibTeX
@article{domenico2018Aginga,
title = {Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes},
author = {Domenico Mattiucci and Giulia Maurizi and Pietro Leoni and Antonella Poloni},
journal = {Cell Transplantation},
year = {2018},
doi = {10.1177/0963689717745890},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Medicine 2017
Citation only
Senescence of mesenchymal stem cells (Review)
International Journal of Hematology 2014
Open access · OA
Cancer gene therapy using mesenchymal stem cells
International Journal of Molecular Sciences 2022
Open access · CC-BY
Aging and Clonal Behavior of Hematopoietic Stem Cells
Frontiers in Immunology 2020
Open access · CC-BY
Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
Cell 2008
Open access · OA
Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair
The EMBO Journal 2017
Open access · OA